Bionovo
Bionovo, Inc. was a pharmaceutical company focused on the discovery and development of drugs derived from botanical sources. The company was headquartered in Emeryville, California, and was publicly traded on the NASDAQ stock exchange under the ticker symbol BNVI.
History[edit | edit source]
Bionovo was founded in 2002 by Dr. Isaac Cohen and Dr. Mary Tagliaferri. The company aimed to develop novel treatments for cancer and women's health, leveraging traditional Chinese medicine and modern scientific techniques.
Research and Development[edit | edit source]
Bionovo's research primarily focused on two main areas: oncology and women's health. The company's lead product candidates included:
- Menerba - A drug candidate for the treatment of menopausal symptoms.
- Bezielle - An investigational drug for the treatment of breast cancer.
Menerba[edit | edit source]
Menerba was designed to treat menopausal symptoms such as hot flashes and night sweats. It was a selective estrogen receptor beta agonist, which aimed to provide the benefits of estrogen without the associated risks of hormone replacement therapy.
Bezielle[edit | edit source]
Bezielle was developed for the treatment of advanced breast cancer. It was derived from a botanical source and aimed to induce cancer cell death without harming normal cells.
Clinical Trials[edit | edit source]
Bionovo conducted several clinical trials to evaluate the safety and efficacy of its drug candidates. The company faced challenges in advancing its products through the clinical trial phases, which ultimately impacted its financial stability.
Financial Challenges and Closure[edit | edit source]
Despite initial promise, Bionovo struggled with financial difficulties. The company faced challenges in securing sufficient funding to continue its research and development activities. In 2012, Bionovo announced that it was suspending its clinical trials due to a lack of funds. The company eventually ceased operations and filed for bankruptcy.
Legacy[edit | edit source]
Bionovo's work contributed to the understanding of botanical sources in drug development, particularly in the areas of oncology and women's health. Although the company did not succeed in bringing its products to market, its research efforts provided valuable insights for future studies.
Related Pages[edit | edit source]
Categories[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD